Overall rank by patents
#3,588
Across all tracked assignees
USPTO PatentsView assignee record - 102 granted patents across 21 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Aveva holds 102 US patents across 21 technology areas, rank #3,588 of 50,000 tracked assignees.
Aveva Software, Llc has been granted 102 US utility patents between 2019 and 2025, placing Aveva Software, Llc at rank #3,588 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.4 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, Aveva Software, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Aveva sits between 3form, Llc (102 patents, rank #3,584) and Corcept Therapeutics Incorporated (102 patents, rank #3,592) - the closest US assignees by grant volume. The composite Innovation Score of 54.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 99 grants, compared with 3 in the 2015–2019 window, a +3200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aveva Software, Llc's 17.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aveva Software, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
3form, LLC
102 patents
ACIST MEDICAL SYSTEMS INC.
102 patents
AMARIN PHARMACEUTICALS IRELAND LIMITED
102 patents
Afero, Inc.
102 patents
BOSTIK SA
102 patents
CENTRAL SOUTH UNIVERSITY
102 patents
Colder Products Company
102 patents
Corcept Therapeutics Incorporated
102 patents
Aveva Software, LLC
102 patents
What this shows Aveva holds 102 patents at rank #3,588, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,588 in granted patent volume.
Other assignees with the most granted patents in Aveva's primary technology class.
Aveva's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 3 | 2.9% |
| 2020 | 6 | 5.9% |
| 2021 | 25 | 24.5% |
| 2022 | 25 | 24.5% |
| 2023 | 18 | 17.6% |
| 2024 | 16 | 15.7% |
| 2025 | 9 | 8.8% |
Top 15 of 21 technology areas
Overall rank by patents
#3,588
Across all tracked assignees
54.2 out of 100
How to use this portfolio
Aveva's 102 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.